false
OasisLMS
Catalog
SCCM Resource Library
Beyond Cytokines: Alternative Targets for Host-Bas ...
Beyond Cytokines: Alternative Targets for Host-Based Blood Purification
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the speaker discusses alternative targets for host-based blood purification in the treatment of sepsis. They highlight the need for extracorporeal blood therapy due to the increased incidence of drug-resistant pathogens and a lack of novel antimicrobial therapies. The speaker explains the immune response to pathogen exposure, including the release of cytokines and the potential for organ dysfunction. They then discuss three filters or cartridges that are currently being evaluated in clinical trials. The first is the Seraph cartridge, which mimics the function of the endothelial glycocalyx and has shown promise in reducing mortality in patients with severe COVID-19. The second is the polymyxin B cartridge, which binds to endotoxins and has had conflicting results in clinical trials. And the third is the selective cytopheretic device, which removes activated neutrophils and monocytes from circulation, leading to immunomodulation. The speaker concludes by stating that while there is growing evidence for the use of these therapies, many questions still need to be answered through further research.
Asset Subtitle
Procedures, Sepsis, 2023
Asset Caption
Type: one-hour concurrent | Extracorporeal Blood Purification for Shock Redux: Where Are We in 2023? (SessionID 1119343)
Meta Tag
Content Type
Presentation
Knowledge Area
Procedures
Knowledge Area
Sepsis
Membership Level
Professional
Membership Level
Select
Tag
Extracorporeal Membrane Oxygenation ECMO
Tag
Cytokines
Year
2023
Keywords
host-based blood purification
extracorporeal blood therapy
cytokines release
Seraph cartridge
immunomodulation
×
Please select your language
1
English